Biophysicists Describe New Gating Action of Acetylcholine Receptor

April 19, 2007
Biophysicists Describe New Gating Action of Acetylcholine Receptor
Biophysicist Anthony Auerbach has described a formerly unknown action of the acetylcholine receptor channel in a paper in Nature.

A formerly unknown action of the acetylcholine receptor channel, a protein that regulates the electrical activity of nerve and muscle cells, is described by biophysicists at the University at Buffalo in the April 19 issue of the journal Nature.

Acetylcholine is a neurotransmitter that carries chemical messages across certain brain synapses and across all human nerve-muscle synapses. Acetylcholine receptors bind the neurotransmitter and set in motion a cascade of molecular activity that ultimately results in thought or motion.

"The acetylcholine receptor channel is a molecule-sized valve that opens and closes to regulate the flow of electricity in nerve and muscle cells," said Anthony L. Auerbach, Ph.D., UB professor of physiology and biophysics in the UB School of Medicine and Biomedical Sciences and senior author on the study.

"Before our work, most scientists thought that this protein had a small number of moving parts, perhaps even just one. Also, they thought that these parts moved, between closed and open, smoothly and nearly instantaneously. Our work has shown that the receptor is made up of a much larger number of moving parts, maybe 20 or so, and that these parts jiggle about when they move."

Prasad G. Purohit, Ph.D., postdoctoral associate working with Auerbach, is first author on the paper. Ananya Mitra, a doctoral student in the laboratory, also contributed to the study.

The researchers use a technique called single-molecule kinetic analysis to probe the transition state of the receptor's "gating mechanism," and to estimate the timing of motions within the protein's opening process.

"Perhaps this newfound understanding of how a protein machine works, how it changes shape in order to carry out its appointed task, will someday lead to better protein engineering and drug design," said Auerbach. "If you want to build a better protein, or to modify its function, an important first step is to understand the ones nature has given us."

Auerbach has conducted research for 18 years into the molecular processes involved in protein activity in the nervous system and on how synaptic receptors are activated by their transmitters. He and scientists working in his laboratory now are studying how the subunits that form the receptor work together, and how the protein limits its receptiveness to signaling mechanisms.

Source: University at Buffalo

Explore further: Scientists make first crystal model of under-diagnosed autoimmune disease

Related Stories

Scientists make first crystal model of under-diagnosed autoimmune disease

June 13, 2017
As a molecular biologist, Kaori Noridomi gets an up-close view of the targets of her investigations. But when she began studying the molecular structures of a rarely diagnosed autoimmune disorder, myasthenia gravis, she decided ...

Nicotinic acetylcholine receptors in the pathophysiology of Alzheimer's disease

June 17, 2016
Nicotinic acetylcholine receptors (nAChRs) have been pursued for decades as potential molecular targets to treat cognitive dysfunction in Alzheimer's disease (AD) due to their demonstrated role in processes underlying cognition ...

Genes for learning, remembering, forgetting: Proteins important in embryos found to change the adult brain

March 29, 2012
Certain genes and proteins that promote growth and development of embryos also play a surprising role in sending chemical signals that help adults learn, remember, forget and perhaps become addicted, University of Utah biologists ...

New finding about a protein that enables our brains and muscles to talk

November 28, 2016
A huge colony of receptors must be optimally positioned and functioning on our muscle cells for our brains to talk with our bodies so we can walk and breathe.

Researchers find protein essential for cognition, mental health

July 1, 2013
The ability to maintain mental representations of ourselves and the world—the fundamental building block of human cognition—arises from the firing of highly evolved neuronal circuits, a process that is weakened in schizophrenia. ...

Efficacy of potential therapy for autoimmune disorder of muscle weakness

October 7, 2014
Nearly 60,000 Americans suffer from myasthenia gravis (MG), a non-inherited autoimmune form of muscle weakness. The disease has no cure, and the primary treatments are nonspecific immunosuppressants and inhibitors of the ...

Recommended for you

Make way for hemoglobin

August 18, 2017
Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is ...

Two-step process leads to cell immortalization and cancer

August 17, 2017
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally ...

Female mouse embryos actively remove male reproductive systems

August 17, 2017
A protein called COUP-TFII determines whether a mouse embryo develops a male reproductive tract, according to researchers at the National Institutes of Health and their colleagues at Baylor College of Medicine, Houston. The ...

New Pathology Atlas maps genes in cancer to accelerate progress in personalized medicine

August 17, 2017
A new Pathology Atlas is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns ...

New technique overcomes genetic cause of infertility

August 17, 2017
Scientists have created healthy offspring from genetically infertile male mice, offering a potential new approach to tackling a common genetic cause of human infertility.

Inhibiting a protein found to reduce progression of Alzheimer's and ALS in mice

August 17, 2017
(Medical Xpress)—A team of researchers with Genetech Inc. and universities in Hamburg and San Francisco has found that inhibiting the creation of a protein leads to a reduction in the progression of Alzheimer's disease ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.